Titan Biotech Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹56.51 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.97 per cent from ₹54.35 crore. This corresponds to a year-on-year *(YoY) growth of 47.62 per cent.
Operating Profit
Operating Profit stands at ₹10.83 crore, reflecting a quarter-on-quarter *(QoQ) increase of 16.20 per cent from ₹9.32 crore. This corresponds to a year-on-year *(YoY) growth of 123.30 per cent.
PBDT
PBDT stands at ₹12.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.33 per cent from ₹11.33 crore. This corresponds to a year-on-year *(YoY) growth of 81.69 per cent.
Profit Before Tax
Profit Before Tax stands at ₹11.23 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.97 per cent from ₹10.12 crore. This corresponds to a year-on-year *(YoY) growth of 97.02 per cent.
Net Profit
Net Profit stands at ₹8.53 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.92 per cent from ₹7.76 crore. This represents a 94.31 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Titan Biotech Ltd Earnings
- YOY
- QOQ
Titan Biotech Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Titan Biotech Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Titan Biotech Ltd Financial Reports
Titan Biotech Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Titan Biotech | 0.85% | -3.80% | -10.31% | 102.09% | 126.59% | 417.20% |
| Kwality Pharma | -2.42% | 4.18% | 36.06% | 48.88% | 144.59% | 146.72% |
| Sai Parenteral's | 8.21% | 9.03% | 10.45% | 30.31% | 30.31% | 30.31% |
| Indoco Remedies | 0.86% | 9.08% | 0.31% | 5.20% | -18.92% | -18.33% |
| Venus Remedies | 5.00% | 15.75% | 37.62% | 107.03% | 76.85% | 192.69% |
| NGL Fine Chem | 3.80% | 2.35% | 28.67% | 20.28% | 114.70% | 159.35% |
| Windlas Biotech | 0.84% | 2.04% | -2.20% | 11.23% | 7.40% | -8.28% |
Company Info
Company Information
Chairman & Independent Directo : Rohit Jain
ED / MD / Promoter : Naresh Kumar Singla
ED / MD / Promoter : Suresh Chand Singla
Non-Exec & Non-Independent Dir : Manju Singla
Non-Exec & Non-Independent Dir : Supriya Singla
Independent Non Exe. Director : Dhairya Madan
Independent Non Exe. Director : Brijesh Kumar Singh
Independent Non Exe. Director : Abhishek Agarwal
WTD & Executive Director : Raja Singla
E D & Wholetime Director : Udit Singla
E D & Wholetime Director : Shivom Singla
Independent Non Exe. Director : Debendra Kumar Sabat
Company Sec. & Compli. Officer : CHARANJIT SINGH